Literature DB >> 12933921

Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.

D Aarsland1, I Litvan, D Salmon, D Galasko, T Wentzel-Larsen, J P Larsen.   

Abstract

BACKGROUND: The relation between dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD) is unknown.
OBJECTIVES: To compare the cognitive profiles of patients with DLB and PDD, and compare those with the performance of patients with a subcortical dementia (progressive supranuclear palsy) and a cortical dementia (Alzheimer's disease).
DESIGN: Survey of cognitive features.
SETTING: General community in Rogaland county, Norway, and a university dementia and movement disorder research centre in the USA. PATIENTS: 60 patients with DLB, 35 with PDD, 49 with progressive supranuclear palsy, and 29 with Alzheimer's disease, diagnosed by either standardised clinical procedures and criteria (all PDD and Alzheimer cases and 76% of cases of progressive supranuclear palsy), or necropsy (all DLB cases and 24% of cases of progressive supranuclear palsy). Level of dementia severity was matched using the total score on the dementia rating scale adjusted for age and education. MAIN OUTCOME MEASURES: Dementia rating scale subscores corrected for age.
RESULTS: No significant differences between the dementia rating scale subscores in the PDD and DLB groups were found in the severely demented patients; in patients with mild to moderate dementia the conceptualisation subscore was higher in PDD than in DLB (p = 0.03). Compared with Alzheimer's disease, PDD and DLB had higher memory subscores (p < 0.001) but lower initiation and perseveration (p = 0.008 and p=0.021) and construction subscores (p = 0.009 and p = 0.001). DLB patients had a lower conceptualisation subscore (p = 0.004). Compared with progressive supranuclear palsy, PDD and DLB patients had lower memory subscores (p < 0.001).
CONCLUSIONS: The cognitive profiles of patients with DLB and PDD were similar, but they differed from those of patients with Alzheimer's disease and progressive supranuclear palsy. The cognitive pattern in DLB and PDD probably reflects the superimposition of subcortical deficits upon deficits typically associated with Alzheimer's disease.

Entities:  

Mesh:

Year:  2003        PMID: 12933921      PMCID: PMC1738667          DOI: 10.1136/jnnp.74.9.1215

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  33 in total

1.  Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease.

Authors:  H I Hurtig; J Q Trojanowski; J Galvin; D Ewbank; M L Schmidt; V M Lee; C M Clark; G Glosser; M B Stern; S M Gollomp; S E Arnold
Journal:  Neurology       Date:  2000-05-23       Impact factor: 9.910

2.  Normative data for the Mattis Dementia Rating Scale.

Authors:  J A Lucas; R J Ivnik; G E Smith; D L Bohac; E G Tangalos; E Kokmen; N R Graff-Radford; R C Petersen
Journal:  J Clin Exp Neuropsychol       Date:  1998-08       Impact factor: 2.475

3.  Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.

Authors:  N J Cordato; G M Halliday; A J Harding; M A Hely; J G Morris
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease.

Authors:  R Fama; E V Sullivan; P K Shear; L Marsh; J A Yesavage; J R Tinklenberg; K O Lim; A Pfefferbaum
Journal:  Arch Neurol       Date:  1997-06

5.  National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity.

Authors:  L N Robins; J E Helzer; J Croughan; K S Ratcliff
Journal:  Arch Gen Psychiatry       Date:  1981-04

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Intellectual, mnemonic, and frontal functions in dementia with Lewy bodies: A comparison with early and advanced Parkinson's disease.

Authors:  John Joseph Downes; Nicholas M. Priestley; Mark Doran; Jose Ferran; Eric Ghadiali; Paul Cooper
Journal:  Behav Neurol       Date:  1998       Impact factor: 3.342

8.  Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias.

Authors:  O L Lopez; I Litvan; K E Catt; R Stowe; W Klunk; D I Kaufer; J T Becker; S T DeKosky
Journal:  Neurology       Date:  1999-10-12       Impact factor: 9.910

9.  The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors:  J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal:  Neurology       Date:  1994-12       Impact factor: 9.910

10.  Cognitive profiles of autopsy-confirmed Lewy body variant vs pure Alzheimer disease.

Authors:  D J Connor; D P Salmon; T J Sandy; D Galasko; L A Hansen; L J Thal
Journal:  Arch Neurol       Date:  1998-07
View more
  51 in total

1.  Association cortex hypoperfusion in mild dementia with Lewy bodies: a potential indicator of cholinergic dysfunction?

Authors:  Tamara G Fong; Sharon K Inouye; Weiying Dai; Daniel Z Press; David C Alsop
Journal:  Brain Imaging Behav       Date:  2011-03       Impact factor: 3.978

2.  Sentence processing in Lewy body spectrum disorder: the role of working memory.

Authors:  Rachel G Gross; Corey T McMillan; Keerthi Chandrasekaran; Michael Dreyfuss; Sharon Ash; Brian Avants; Philip Cook; Peachie Moore; David J Libon; Andrew Siderowf; Murray Grossman
Journal:  Brain Cogn       Date:  2012-01-02       Impact factor: 2.310

3.  Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder.

Authors:  Murray Grossman; Rachel G Gross; Peachie Moore; Michael Dreyfuss; Corey T McMillan; Philip A Cook; Sherry Ash; Andrew Siderowf
Journal:  Brain Lang       Date:  2011-09-29       Impact factor: 2.381

4.  Screening for DSM-IV-TR cognitive disorder NOS in Parkinson's disease using the Mattis Dementia Rating Scale.

Authors:  Gregory M Pontone; Justin Palanci; James R Williams; Susan Spear Bassett
Journal:  Int J Geriatr Psychiatry       Date:  2012-05-24       Impact factor: 3.485

Review 5.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

6.  Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.

Authors:  Sean J Colloby; E David Williams; David J Burn; Jim J Lloyd; Ian G McKeith; John T O'Brien
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-02       Impact factor: 9.236

Review 7.  Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.

Authors:  Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2008-03-06       Impact factor: 7.444

8.  The organization of narrative discourse in Lewy body spectrum disorder.

Authors:  Sharon Ash; Corey McMillan; Rachel G Gross; Philip Cook; Brianna Morgan; Ashley Boller; Michael Dreyfuss; Andrew Siderowf; Murray Grossman
Journal:  Brain Lang       Date:  2011-10       Impact factor: 2.381

9.  Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies.

Authors:  Joanne M Hamilton; David P Salmon; Douglas Galasko; Rema Raman; Jenn Emond; Lawrence A Hansen; Eliezer Masliah; Leon J Thal
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

10.  Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.

Authors:  J A Schneider; Z Arvanitakis; L Yu; P A Boyle; S E Leurgans; D A Bennett
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.